Chinese Journal of Hepatology 2005 Issue 7 A study of the dosage and efficacy of entecavir for treating hepatitis B virus

A study of the dosage and efficacy of entecavir for treating hepatitis B virus
YAO Guang-bi;ZHANG Ding-feng;WANG Bao-en;XU Dao-zhen;ZHOU Xia-qiu;Lei Bing-jun

..............page:484-487

Challenges regarding the treatment of viral hepatitis B
ZHANG Ding-feng

..............page:481-483

Influences of the genotypes of HBV and HBeAg regarding their response to PEG-IFN in chronic hepatitis B patients
FAN He-bin;GUO Ya-bing;LUO Kang-xian;HOU Jin-Lin;WANG Zhan-hui;ZHANG Ming-xia

..............page:488-490

Hepatitis B virus genotypes and alanine aminotransferase levels in HBeAg negative patients with chronic hepatitis B and liver cirrhosis
LI Jun-Qian;ZHUANG Hui;Du Heng;WANG Xiao-hong;DUAN Xue-zhang

..............page:491-493

Clinical investigation of famciclovir in chronic hepatitis B patients irresponsive to alpha interferon treatment
WANG Zhi-yi;GUO Shu-hua;ZHANG Ding-feng;ZHAO You-rong;REN Hong;ZHOU Xia-qiu;XU Dao-zhen;SUN Jing-yuan;YAO Ji-lu;LU Wei-lun

..............page:494-496

Immune response enhanced by genes encoding IFN-alpha 8 and T alpha 1 co-inoculated with HBV DNA vaccine
ZHOU Tao-you;ZHAO Lian-san;CHEN Min;CHEN Shou-chun;WANG Song;LIU Li;TANG Hong

..............page:497-500

Establish a transgenic mice model harboring structural genes of hepatitis C virus
REN Jin-yu;CHENG Guo-Xiang;KONG Xiao-fei;CHEN Jian-Quan;ZHOU Ru-Jiang;LU Zhi-meng

..............page:501-504

Molecular mechanism of HCV NS5A on p53's inhibition of AFP expression in hepatocellular carcinoma cells
GONG Guo-zhong;JIANG Yong-fang;HE Yan;LAI Li-ying;XU Yun;SU Xian-shi

..............page:505-508

Dynamic evolution of MMP-2 gene expression and its enzymatic activities in experimental liver fibrosis
ZHU Yue-ke;WANG Bao-en;SHEN Feng-jun;JIA Ji-dong;MA Hong

..............page:509-512

Correlation between HBsAg, HCV expression in cancerous and pericancer tissues of hepatocellular carcinoma and liver fibrosis markers in serum
XIN Yong-ning;XUAN Shi-ying;SHI Guang-jun;CHEN Hua;SUN Ying;ZHANG Jian

..............page:513-515

Pathological studies of tissue damage in experimental rabbit liver cancer induced by energy controllable steep pulses
WANG Ping-ling;HU Lina;YANG Xiao-jun;LI Jun;SUN Cai-xin;XIONG Lan;YAO Chen-guo;WANG SHI-bin

..............page:516-519

Screening of binding proteins to interferon-alpha promoter DNA by phage display technique
QU Jian-hui;CHENG Jun;ZHANG Ling-xia;ZHONG Yan-wei;LIU Yan;WANG Lin;DAI Jiu-zeng

..............page:520-523

Evaluation of early stage diffused liver lesions with MR functional diffusion-weighted imaging-an experimental study
GUAN Sheng;ZHAO Wei-dong;ZHOU Kang-rong;Peng Wei-jun;TANG Feng;Mao Jian;CAO Guang;SUN Fei

..............page:524-527

Effects of gamma-interferon on gene expression of collagen Ⅰ, Ⅲ and on the tissue inhibitor of metalloprotenase 1 in HSC-T6 cells
MA Hong;MA Xue-mei;YIN Cheng-hong;JIA Ji-dong;WANG Bao-en

..............page:528-530

The changes of ROS and mitochondria membrane potential in HepG2 cells on the pressure of cisplatin
CHEN Wei-qing;SHEN Wei;SHEN Ding-ming

..............page:531-533

Durability of HBeAg seroconversion in lamivudine treatment of chronic hepatitis B patients
ZHU Mei;Xu Bei;YAO Guang-bi

..............page:534-536

Some strategies for the long-term treatment of chronic hepatitis B
REN Hong

..............page:537-538

Management of HBeAg negative chronic hepatitis B
JIA Ji-dong

..............page:539

Antiviral treatment of HBeAg positive chronic hepatitis B
WANG Gui-qiang

..............page:540

Molecular cloning and identification of a novel gene and its relationship to hepatocellular carcinoma
ZHAO Hong-zhi;LI Jing;LIANG Ping;LI Hong-yan;HUANG Xiao-bing

..............page:483,487

The heterogeneity of HCV quasi-species in the hypervariable region and its relationship to interferon therapy
SHI Li-lan;ZHANG Lin;ZHAO Gui-zhen;QIAO Guang-yan

..............page:523,527

Inhibitory effects of a novel trimeric of beta peptide (beta3) on migration and invasion of hepatocellular carcinoma cells
WANG Song-mei;ZHU Jun;LI Yan;PAN Luan-feng;ZHA Xi-Liang;LIU Yin-kun

..............page:541-542

The sensitivity improvement of HBx+HepG2 to CDDP with PD98059
LI Yu-long;CHEN Xiang-yu;DUAN Fang-Ling

..............page:543-544

A report from the Third National Symposium on Liver Failure and Artificial Livers
LI Lan-juan;HUANG Jian-rong;YANG Qian

..............page:555

L-carnitine in the treatment of liver diseases
SHI Jian;LIU Su;XIE Wei-fen

..............page:556-558

du zhe zuo zhe bian zhe

..............page:559

xiao xi

..............page:519,538,544,558,560-封三

Effects of hyperbaric oxygen with free-radical antagonists on the expression and activity of matrix metalloproteinase-2 in rat livers
ZHANG Ai-feng;CHEN Ping-sheng;ZHANG Li-da;ZHANG Xiao-ming;LIU Dong-feng

..............page:545-546

Effects of selective cyclooxygenase-2 inhibitor NS-398 on proliferation and cell cycle progression of hepatocarcinoma cells
ZHANG Ling-yi;WANG Xiang;ZHANG You-cheng;FU Sheng-Jun;MA Li

..............page:547-548

The characterization value of feridex-enhanced MR imaging for focal hepatic lesions in reference to their histological pathology
YANG Han-feng;ZHOU Xiang-ping;YU Jian-qun;SONG Bin;GUANG Yong-song;ZHANG Hong-ying;CHEN Xian

..............page:548-550

Expression of IL-10 in the livers of rats with chronic alcoholic liver diseases
OUYANG Hong;LI You-ming;QIN Yue-hua;ZHANG Yu

..............page:551-552

Effects of herbal compound 861 on the ultrastructure and cytoskeleton protein expression of hepatic stellate cells
DING Hui-guo;SHANG Hong-wei;WANG Xing-cui;TANG Su-zhen;SUN Yi-Lin;JIA Ji-dong;ZHAO Chun-hui;WANG Bao-en

..............page:553-554

Pedunculated (exophytic) hepatocellular carcinoma-a report of two cases
WU Gang;HUANG Jian-zhao;GU Hong-guang

..............page:490